| DAA2591 |
Advanced glycation end products increases in aging human skeletal muscle |
Physiological |
muscle |
Human |
— |
— |
|
| DAA1978 |
Age differences in classical conditioning of the eyelid response |
Physiological |
eyelid |
Human |
— |
— |
|
| DAA551 |
AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast) |
Molecular |
skeletal muscle |
Human |
AHSA2 |
3.0% Increase Gene Expression Level |
|
| DAA6 |
AHNAK nucleoprotein |
Molecular |
brain |
Human |
AHNAK |
13.0% Increase Gene Expression Level |
|
| DAA1328 |
AHNAK nucleoprotein 2 |
Molecular |
hematological system |
Mouse |
Ahnak2 |
81.0% Increase Gene Expression Level |
|
| DAA804 |
Air flow resistance increases |
Physiological |
lung |
Human |
— |
— |
|
| DAA474 |
A kinase (PRKA) anchor protein 7 |
Molecular |
skeletal muscle |
Human |
AKAP7 |
3.0% Decrease Gene Expression Level |
|
| DAA1247 |
albumin |
Molecular |
brain |
Mouse |
Alb |
88.0% Increase Gene Expression Level |
|
| DAA698 |
Albumin levels decrease |
Physiological |
plasma |
Human |
— |
— |
|
| DAA2431 |
aldehyde dehydrogenase 1A1 decreases with age |
Molecular |
dermis |
Human |
ALDH1A1 |
30.3% Decrease DNA Methylation |
|
| DAA7 |
aldehyde dehydrogenase 9 family, member A1 |
Molecular |
brain |
Human |
ALDH9A1 |
10.0% Increase Gene Expression Level |
|
| DAA1721 |
aldehyde dehydrogenase family 1, subfamily A1 |
Molecular |
muscle |
Mouse |
Aldh1a1 |
6.0% Increase Gene Expression Level |
|
| DAA1277 |
aldo-keto reductase family 1, member C18 |
Molecular |
cochlea |
Mouse |
Akr1c18 |
20.0% Decrease Gene Expression Level |
|
| DAA2428 |
aldo-keto reductase family 1; member C3 decreases with age |
Molecular |
dermis |
Human |
AKR1C3 |
19.3% Decrease DNA Methylation |
|
| DAA912 |
Aldosterone secretion, blood levels and clearance decrease |
Physiological |
plasma, adrenal gland |
Human |
— |
— |
|
| DAA912 |
Aldosterone secretion, blood levels and clearance decrease |
Physiological |
plasma, adrenal gland |
Human |
— |
— |
|
| DAA1969 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) mRNA expression decrease |
Molecular |
heart |
Mouse |
Alox5 |
— |
|
| DAA1967 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) mRNA expression increase |
Molecular |
cerebellum |
Mouse |
— |
— |
|
| DAA1965 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) mRNA expression increase |
Molecular |
heart |
Mouse |
Alox5 |
— |
|
| DAA1964 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase |
Molecular |
cerebellum |
Mouse |
Alox5 |
— |
|
| DAA1966 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase |
Molecular |
hippocampus |
Mouse |
— |
— |
|
| DAA1963 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase |
Molecular |
heart |
Mouse |
Alox5 |
— |
|
| DAA269 |
alpha-kinase 2 |
Molecular |
kidney |
Human |
ALPK2 |
20.0% Increase Gene Expression Level |
|
| DAA475 |
alpha-kinase 3 |
Molecular |
skeletal muscle |
Human |
ALPK3 |
6.0% Increase Gene Expression Level |
|
| DAA2035 |
Alterations in frequency, developmental potential and gene expression profile in hematopoietic stem cells |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|